Low dose naltrexone (LDN) is a medication that is typically used for the treatment of opioid addiction, but it has also shown promising results in the treatment of a variety of other medical conditions, including Lyme disease and other tick-borne illnesses. LDN works by binding to specific receptors in the body, blocking the effects of certain neurotransmitters and modulating the immune system.
Research has shown that LDN has the ability to reduce inflammation, improve immune function, and alleviate symptoms in individuals with Lyme disease and other tick-borne illnesses. A study published in the Journal of Clinical Psychology found that LDN was effective in reducing symptoms of fatigue, joint pain, and neurological problems in individuals with Lyme disease, while another study published in the Journal of Medical Microbiology found that LDN improved immune function and reduced the burden of persistent infections in individuals with tick-borne illnesses.
LDN is typically administered at a low dose, typically around 1.5 to 4.5 mg, which is much lower than the doses typically used for addiction treatment. This low dose is thought to be effective because it triggers the release of beta-endorphins, which have a regulatory effect on the immune system and help to reduce inflammation and oxidative stress.
LDN is considered a safe and well-tolerated treatment for Lyme disease and other tick-borne illnesses, with few side effects. The most common side effect is mild sleep disturbances, which typically resolve on their own after a few days of treatment. LDN is also thought to be a safe and effective alternative to antibiotics, which can have a negative impact on the gut microbiome and contribute to the development of antibiotic-resistant infections.
In conclusion, low dose naltrexone has shown promising results in the treatment of Lyme disease and other tick-borne illnesses, reducing symptoms, improving immune function, and promoting overall health and well-being. If you are considering LDN for the treatment of your tick-borne illness, it is important to work closely with a healthcare provider to determine if it is right for you, and to monitor your symptoms and response to treatment.
Latest from the Blog
The Death of Red Dye #3
January 15, 2025What Is Red Dye No. 3? Red Dye No. 3, or Erythrosine, is a synthetic food color derived from coal tar. It was first approved by the FDA in the 1950s and quickly became one of the most popular artificial colors in food and cosmetics. Red Dye No. 3 was used in everything from candies, […] Read more
Latest from the Blog
Do You Know What Is In Your Protein Powder?
What’s Really in Your Protein Powder? Understanding the Risks Protein powders are a staple in many health-conscious diets, from athletes seeking muscle recovery to those simply aiming to boost their daily protein intake. With a wide variety of options available, choosing the right one can feel overwhelming. However, recent findings have raised concerns about what’s […] Read more